Why Is JOBY AVIATION INC A (JOBY) Stock Moving Today?

JOBY stock is moving sharply lower today, continuing a broader decline in air taxi stocks that have fallen 40% to 60% in 2026. The stock has fallen below $10 for the first time since early 2026 and is trading at $7.20 as of the close of the 8th consecutive session, down 9.1% from $7.93. The pullback is driven by a combination of deteriorating investor sentiment, heavy insider selling, and broader sector weakness.

What Happened

JOBY stock has been under pressure as the air taxi sector faces growing skepticism. The stock tested the $8 support level this week, with analysts and investors questioning the long-term viability of the industry amid rising costs and delayed commercial timelines. Recent insider transactions have also raised concerns, with key executives including CEO Joeben Bevirt and Chief Product Officer Eric Allison selling shares in early July. These sales, totaling $18.9 million across 18 transactions in the last 90 days, have contributed to a negative market perception. Meanwhile, a new manufacturing joint venture with Toyota, announced earlier this year, has yet to translate into investor confidence, as the sector continues to struggle with profitability and execution risks.

What The Data Shows

JOBY has a market capitalization of $7.1 billion and is unprofitable with an EPS of -1.10 over the trailing twelve months. Despite a dramatic 69,873.9% year-to-date revenue increase, the stock has a beta of 2.71, making it highly volatile. Over the past 30 days, sentiment has declined from an average of 58 to 47 out of 100. The stock has traded between $6.89 and $20.95 in the last 52 weeks. In the last 8 sessions, it has moved from $7.93 to $7.20. The stock has seen no insider buying in the last 90 days, while short interest has also increased ahead of the expected flying car rollout.

What To Watch

JOBY does not have an upcoming earnings date listed. Investors should monitor the breadth of coverage and sentiment shifts as the sector awaits progress on commercialization and regulatory approvals.